Selective MYC 5' amplification in postirradiation/lymphedema-associated angiosarcoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Postirradiation/lymphedema-associated angiosarcoma (PLAS) is a rare malignancy.
• The role of MYC gene amplification in PLAS pathogenesis is not fully understood.
• Distinguishing PLAS from other carcinomas can be challenging.

Purpose of the Study:

• To investigate the co-amplification of an endothelium-specific enhancer with the MYC gene in PLAS.
• To evaluate the diagnostic utility of MYC break-apart fluorescence in situ hybridization (FISH) for differentiating PLAS from carcinoma.
• To analyze the association between MYC-co-amplified regions and cell type-specific enhancers.

Main Methods:

• MYC break-apart FISH was performed on six PLAS cases and 23 MYC-amplified carcinoma cases.
• MYC-co-amplified regions were analyzed using cBioportal.
• Endothelium-specific active enhancers were identified using ENCODE chromatin immunoprecipitation-sequencing data (H3K4me1 and H3K27ac).

Main Results:

• Selective 5' MYC amplification was observed in all PLAS cases.
• Carcinomas, including breast cancers, showed dual-signal MYC amplification.
• Angiosarcoma exhibited 5' skewing of the MYC-co-amplified region, linked to an endothelium-specific enhancer upstream of MYC.

Conclusions:

• MYC break-apart FISH is a valuable tool for distinguishing PLAS from carcinoma.
• The findings support the hypothesis of MYC co-amplification with an endothelium-specific enhancer in PLAS.
• Further research with larger cohorts and advanced genomic/epigenetic techniques is warranted.